These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
849 related items for PubMed ID: 6237195
1. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive. Batzer FR. J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195 [Abstract] [Full Text] [Related]
2. [Pros and cons of triphasic oral contraception]. Berdah J. Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512 [Abstract] [Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A, De Leo V. Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [Abstract] [Full Text] [Related]
4. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference? Speroff L. Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035 [Abstract] [Full Text] [Related]
5. [Oral contraception and its beneficial gynecological effects]. Belaisch J, Hommais-loufrani B. Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188 [Abstract] [Full Text] [Related]
7. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U, Dubois M. Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [Abstract] [Full Text] [Related]
8. [Oral contraception: failures and risks]. Foussard-blanpin O, Paillot-renaud P, Bruneau-bigot A. Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590 [Abstract] [Full Text] [Related]
9. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol. Akerlund M. Acta Obstet Gynecol Scand Suppl; 1997 Nov; 164():63-5. PubMed ID: 9225641 [Abstract] [Full Text] [Related]
10. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V. Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [Abstract] [Full Text] [Related]
11. The triphasics: insights for effective clinical use. Youngkin EQ, Miller LG. Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267 [Abstract] [Full Text] [Related]
12. Current perspectives on combination oral contraceptives. Smith MA, Youngkin EQ. Clin Pharm; 1984 Feb; 3(5):485-96. PubMed ID: 6386284 [Abstract] [Full Text] [Related]
13. OC practice guidelines: minimizing side effects. Darney PD. Int J Fertil Womens Med; 1997 Feb; Suppl 1():158-69. PubMed ID: 9168375 [Abstract] [Full Text] [Related]
14. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X. NPN Med; 1985 Apr 02; 5(88):471-6. PubMed ID: 12315304 [Abstract] [Full Text] [Related]
15. Rationale for a triphasic oral contraceptive. Pasquale SA. J Reprod Med; 1984 Jul 02; 29(7 Suppl):560-7. PubMed ID: 6481710 [Abstract] [Full Text] [Related]
16. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D, Wildemeersch D, Verougstraete A, Creatsas G. Int J Fertil Menopausal Stud; 1995 Jul 02; 40 Suppl 2():73-9. PubMed ID: 8574253 [Abstract] [Full Text] [Related]
17. Pill formulations and their effect on lipid and carbohydrate metabolism. Brooks PG. J Reprod Med; 1984 Jul 02; 29(7 Suppl):539-46. PubMed ID: 6481707 [Abstract] [Full Text] [Related]
18. [How to choose an oral contraceptive in 1984]. Rozenbaum H. Contracept Fertil Sex (Paris); 1984 Nov 02; 12(11):1201-6. PubMed ID: 12266609 [Abstract] [Full Text] [Related]